Sentence examples for response benefits from inspiring English sources

Brain metastases patients achieving sufficient E-RBC (⩾483  μg/ml) and receiving at least seven of 10 efaproxiral doses were most likely to experience survival and response benefits.

Targets moving in the directions opposite the avatar did not elicit reliable response benefits (vs. no moving item) in Experiment 1 (ts < 1.84, ps >.09), but did so in Experiments 2 and 3 (all ts > 2.20, ps <.05).

This additive pattern led Skarratt et al. (2014) to argue that although attentional capture might occur for dynamic stimuli in general, the response benefits for looming stimuli might be particularly caused by priming of the visuomotor system.

Further confounding the gefitinib story, the absence of an identified population that would attain all the response benefits at the time of the randomized phase II trial led to false assumptions that dose did not matter, resulting in the utilization of the lower dose in the phase III trial comparing gefitinib with standard best supportive care [7].

When the target was the moving object, response benefits were greatest when it was approaching the avatar [toward avatar vs. no moving item: Exp. 1, t(13) = 5.35, p <.005; Exp. 2, t(19) = 7.09, p <.005; Exp. 3, t 1, 15) = 3.07, p <.01].

The model includes six modules: power consumption of EVs, generator set dispatching, charge pricing, user response, benefit evaluation of all stakeholders and charging stations' life-cycle net income.

Response: Benefit sharing?

Tests for humoral immune response benefit lepromatous patients while tests for evaluation of cellular response will aid in the diagnosis of tuberculoid patients.

However, this study does not suggest that future health surveys would gain any response benefit from the inclusion of a prize draw incentive.

In contrast, predictive markers 'are associated with response (benefit) or lack of response to a particular therapy relative to other available therapy' (McShane, 2012) and can be used to identify patients most likely to benefit from a specific therapy.

Interestingly, the combination was well tolerated and demonstrated a significant clinical activity, obtaining an overall response rate of 55%, a clinical response benefit of 82% and a time to progression of 8 months (Saunders et al, 2004).